Trial Profile
Exhaled breath analysis for prediction of response to Mepolizumab in patients with severe asthma.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Acronyms EXPREME
- 27 Sep 2018 New trial record